CIK: 1785894 - Address: C/o Vanda Pharmaceuticals Inc., 2200 Pennsylvania Avenue, Suite 300E, Washington, DC 20037
8 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

9/17/21 08:52
9/15/21
VNDAVanda Pharmaceuticals Inc.DEHealthDrugPharmaceutical PreparationsJones Aranthan IIDCOChief CoM.d14111.660121782D
9/17/21 08:52
9/15/21
VNDAVanda Pharmaceuticals Inc.DEHealthDrugPharmaceutical PreparationsJones Aranthan IIDCOChief CoS.d-27716.490-17-1782D
7/27/21 16:37
7/26/21
VNDAVanda Pharmaceuticals Inc.DEHealthDrugPharmaceutical PreparationsJones Aranthan IIDCOChief CoS-14319.690-7-887D
3/16/21 16:20
3/15/21
VNDAVanda Pharmaceuticals Inc.DEHealthDrugPharmaceutical PreparationsJones Aranthan IIDCOChief CoM.d17011.320151994D
3/16/21 16:20
3/15/21
VNDAVanda Pharmaceuticals Inc.DEHealthDrugPharmaceutical PreparationsJones Aranthan IIDCOChief CoS.d-31917.720-18-1694D
3/3/21 18:40
3/2/21
VNDAVanda Pharmaceuticals Inc.DEHealthDrugPharmaceutical PreparationsJones Aranthan IIDCOChief CoS-7018.040-4-497D
8/14/20 16:39
8/12/20
VNDAVanda Pharmaceuticals Inc.DEHealthDrugPharmaceutical PreparationsJones Aranthan IIDCOChief CoS-8511.810-7-975D
7/29/20 20:17
7/27/20
VNDAVanda Pharmaceuticals Inc.DEHealthDrugPharmaceutical PreparationsJones Aranthan IIDCOChief CoS-7810.620-7-883D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact